{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:45:55Z","timestamp":1793245555698,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"am","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1 R01 HD097129"],"award-info":[{"award-number":["1 R01 HD097129"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesinpediatrics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Pediatrics"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.yapd.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T07:56:19Z","timestamp":1655452579000},"page":"203-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Clinical Indications for Growth Hormone Therapy"],"prefix":"10.1016","volume":"69","author":[{"given":"Melinda","family":"Danowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adda","family":"Grimberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.yapd.2022.03.005_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-1 treatment in children children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-1 deficiency","volume":"86","author":"Grimberg","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.yapd.2022.03.005_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000502231","article-title":"Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective","volume":"92","author":"Collett-Solberg","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.yapd.2022.03.005_bib3","first-page":"1","article-title":"Congenital Hypopituitarism During the Neonatal Period: Epidemiology, Pathogenesis, Therapeutic Options, and Outcome","volume":"8","author":"Bosch","year":"2021","journal-title":"Front Pediatr"},{"issue":"3","key":"10.1016\/j.yapd.2022.03.005_bib4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.23736\/S0026-4946.20.05821-1","article-title":"Dilemmas of Growth Hormone Treatment for GH Deficiency and Idiopathic Short Stature: Defining, Distinguishing, and Deciding","volume":"72","author":"Halas","year":"2020","journal-title":"Minerva Pediatr"},{"issue":"3","key":"10.1016\/j.yapd.2022.03.005_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jpeds.2006.05.010","article-title":"Growth hormone deficiency, low levels of adiponectin, and unfavorable plasma lipid and lipoproteins","volume":"149","author":"Lanes","year":"2006","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.yapd.2022.03.005_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/EJE-16-1024","article-title":"Early growth hormone treatment start in childhood growth hormone deficiency improves near adult height: analysis from NordiNet\u00ae International Outcome Study","volume":"177","author":"Polak","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.yapd.2022.03.005_bib7","first-page":"126","article-title":"Measuring Growth Hormone and Insulin-like Growth Factor-1 in Infants: What is Normal?","volume":"11","author":"Hawkes","year":"2013","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.yapd.2022.03.005_bib8","first-page":"499","article-title":"Insulin-like growth factor-1 is a marker for the nutritional state","volume":"13","author":"Hawkes","year":"2015","journal-title":"Ped Endocrinol Rev"},{"issue":"6","key":"10.1016\/j.yapd.2022.03.005_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1515\/jpem-2021-0045","article-title":"Provocative growth hormone testing in children: how did we get here and where do we go now?","volume":"34","author":"Kamoun","year":"2021","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.yapd.2022.03.005_bib10","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ajmg.a.33951","article-title":"Nutritional phases in prader-willi syndrome","volume":"155a","author":"Miller","year":"2011","journal-title":"Am J Med Genet A"},{"issue":"11","key":"10.1016\/j.yapd.2022.03.005_bib11","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1210\/jc.2008-0649","article-title":"Recommendations for the diagnosis and management of Prader-Willi Syndrome","volume":"93","author":"Goldstone","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2022.03.005_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejhg.2008.165","article-title":"Prader-Willi syndrome","volume":"17","author":"Cassidy","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.yapd.2022.03.005_bib13","first-page":"10","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Gen Med"},{"issue":"6","key":"10.1016\/j.yapd.2022.03.005_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/edrv.22.6.0447","article-title":"Endocrine Dysfunction in Prader-Willi Syndrome: A Review with Special Reference to GH","volume":"22","author":"Burman","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.yapd.2022.03.005_bib15","first-page":"591","article-title":"Growth Hormone Improves Body Composition and Motor Development in Infants with Prader-Willi Syndrome After Six Months","volume":"17","author":"Whitman","year":"2004","journal-title":"J\u00a0Pediatr Endocrinol Met"},{"key":"10.1016\/j.yapd.2022.03.005_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000319709","article-title":"Effects on Growth and Metabolism of Growth Hormone Treatment for 3 years in 36 Children with Prader-Willi Syndrome","volume":"75","author":"Colmenares","year":"2011","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"10.1016\/j.yapd.2022.03.005_bib17","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jc.2009-1389","article-title":"Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi Syndrome","volume":"95","author":"Carrel","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.yapd.2022.03.005_bib18","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/jc.2007-2294","article-title":"High Prevalence of Central Adrenal Insufficiency in Patients with Prader-Willi Syndrome","volume":"93","author":"de Lind van Winjgaarden","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2022.03.005_bib19","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s40618-015-0312-9","article-title":"Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings","volume":"38","author":"Angulo","year":"2015","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.yapd.2022.03.005_bib20","first-page":"830","article-title":"Perinatal outcome in SGA births defined by customized versus population-based birthweight standards","volume":"108","author":"Clausson","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.yapd.2022.03.005_bib21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.bpobgyn.2009.06.003","article-title":"Risk factors for small for gestational age infants","volume":"23","author":"McCowan","year":"2009","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.yapd.2022.03.005_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000449275","article-title":"Small at Birth, but How Small? The Definition of SGA Revisited","volume":"86","author":"Zeve","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.yapd.2022.03.005_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1651-2227.1994.tb13292.x","article-title":"Natural growth in children born small for gestational age with and without catch-up growth","volume":"399","author":"Albertsson-Wikland","year":"1994","journal-title":"Acta Paediatr"},{"issue":"11","key":"10.1016\/j.yapd.2022.03.005_bib24","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1210\/jc.2012-1987","article-title":"Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial","volume":"97","author":"Lem","year":"2012","journal-title":"JCEM"},{"issue":"1","key":"10.1016\/j.yapd.2022.03.005_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2265.2004.02171.x","article-title":"Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA)","volume":"62","author":"Arends","year":"2005","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.yapd.2022.03.005_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/jc.2006-1073","article-title":"Risk Factors for Diabetes Mellitus Type 2 and Metabolic Syndrome are Comparable for Previously Growth Hormone-Treated Young Adults Born Small for Gestational Age (SGA) and Untreated Short SGA Controls","volume":"92","author":"van Dijk","year":"2007","journal-title":"JCEM"},{"key":"10.1016\/j.yapd.2022.03.005_bib27","first-page":"113","article-title":"Growth Hormone Treatment for Idiopathic Short Stature","volume":"16","author":"Cutfiled","year":"2018","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.yapd.2022.03.005_bib28","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1210\/jc.2008-0707","article-title":"Dose-dependent effect of growth hormone o final height in children with short stature without growth hormone deficiency","volume":"93","author":"Albertsson-Wikland","year":"2008","journal-title":"JCEM"},{"issue":"5","key":"10.1016\/j.yapd.2022.03.005_bib29","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jcem.87.5.8477","article-title":"Growth Hormone and Low Dose Estrogen in Turner Syndrome: Results of a United States Multi-Center Trial to Near-Final Height","volume":"87","author":"Quigley","year":"2002","journal-title":"JCEM"},{"issue":"3","key":"10.1016\/j.yapd.2022.03.005_bib30","first-page":"1","article-title":"Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting","volume":"177","author":"Gravholt","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.yapd.2022.03.005_bib31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41574-019-0224-4","article-title":"Turner syndrome: mechanisms and management","volume":"15","author":"Gravholt","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.yapd.2022.03.005_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/2042018817746291","article-title":"Current best practice in the management of Turner syndrome","volume":"9","author":"Shankar","year":"2018","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.yapd.2022.03.005_bib33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1210\/jc.2007-1723","article-title":"Long-Term Safety of Recombinant Human Growth Hormone in Turner Syndrome","volume":"93","author":"Bolar","year":"2008","journal-title":"JCEM"},{"key":"10.1016\/j.yapd.2022.03.005_bib34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jpag.2016.03.005","article-title":"Hypogonadism and Sex Steroid Replacement Therapy in Girls with Turner Syndrome","volume":"29","author":"Gawlik","year":"2016","journal-title":"J\u00a0Pediatr Adol Gynec"},{"issue":"5","key":"10.1016\/j.yapd.2022.03.005_bib35","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1210\/jc.2017-02183","article-title":"Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations","volume":"103","author":"O Klein","year":"2018","journal-title":"JCEM"},{"issue":"5","key":"10.1016\/j.yapd.2022.03.005_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41436-020-01046-0","article-title":"ACMG Professional Practice and Guidelines Committee. Focused Revision: ACMG practice resource: Genetic evaluation of short stature","volume":"23","author":"Mintz","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.yapd.2022.03.005_bib37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/jmg.2006.046581","article-title":"Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinufficiency","volume":"44","author":"Rappold","year":"2007","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.yapd.2022.03.005_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000444596","article-title":"SHOX Haploinsufficiency as a Cause of Syndromic and Nonsyndromic Short Stature","volume":"7","author":"Fukami","year":"2016","journal-title":"Mol Syndromol"},{"issue":"163","key":"10.1016\/j.yapd.2022.03.005_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13052-020-00927-z","article-title":"SHOX deficiency in children with growth impairment: evaluation of known and new auxological and radiological indicators","volume":"46","author":"Vannelli","year":"2020","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.yapd.2022.03.005_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000452973","article-title":"Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial","volume":"87","author":"Benabbad","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.yapd.2022.03.005_bib41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/pr.2017.247","article-title":"Improving clinical diagnosis in SHOX deficiency: the importance of growth velocity","volume":"83","author":"Genoni","year":"2018","journal-title":"Pediatr Rese"},{"key":"10.1016\/j.yapd.2022.03.005_bib42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/pr.2016.233","article-title":"Prevalence of SHOX haploinsufficiency among short statured children","volume":"81","author":"Marstrand-Joergensen","year":"2017","journal-title":"Pediatr Res"},{"key":"10.1016\/j.yapd.2022.03.005_bib43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41431-020-0676-y","article-title":"Variants in the 5\u2019UTR reduce SHOX expression and contribute to SHOX haploinsufficiency","volume":"29","author":"Babu","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.yapd.2022.03.005_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1926","article-title":"Germline gain-of-function mutations in SOS1 cause Noonan syndrome","volume":"39","author":"Roberts","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.yapd.2022.03.005_bib45","first-page":"37","article-title":"Noonan Syndrome","volume":"89","author":"Bhambhani","year":"2014","journal-title":"AFP"},{"key":"10.1016\/j.yapd.2022.03.005_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5114\/aoms.2017.64720","article-title":"Noonan syndrome- a new survey","volume":"13","author":"Tafazoli","year":"2017","journal-title":"Arch Med Sci"},{"issue":"9","key":"10.1016\/j.yapd.2022.03.005_bib47","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/ajmg.a.38362","article-title":"Noonan syndrome in diverse populations","volume":"173","author":"Kruszka","year":"2017","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.yapd.2022.03.005_bib48","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines","volume":"126","author":"Romano","year":"2010","journal-title":"Pediatr"},{"issue":"4","key":"10.1016\/j.yapd.2022.03.005_bib49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.6065\/apem.2018.23.4.176","article-title":"Growth hormone therapy in patients with Noonan syndrome","volume":"23","author":"Seo","year":"2018","journal-title":"Ann Pediatr Endocrinol Met"},{"key":"10.1016\/j.yapd.2022.03.005_bib50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.6065\/apem.2016.21.1.26","article-title":"Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome","volume":"21","author":"Jeong","year":"2016","journal-title":"Ann Pediatr Endocrinol Met"},{"issue":"3","key":"10.1016\/j.yapd.2022.03.005_bib51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4274\/jcrpe.3013","article-title":"The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study","volume":"8","author":"Siklar","year":"2016","journal-title":"JCRPE"},{"key":"10.1016\/j.yapd.2022.03.005_bib52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000500264","article-title":"Impact of Growth Hormone Therapy on Adult Height in Patients with PTPN11 Mutations Related to Noonan Syndrome","volume":"91","author":"Malaquias","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.yapd.2022.03.005_bib53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000498859","article-title":"Treatment with Growth Hormone in Noonan Syndrome Observed during 25 years of KIGS: Near Adult Height and Outcome Prediction","volume":"91","author":"Ranke","year":"2019","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"10.1016\/j.yapd.2022.03.005_bib54","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2015-1002","article-title":"Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy- A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee","volume":"100","author":"Raman","year":"2015","journal-title":"JCEM"},{"key":"10.1016\/j.yapd.2022.03.005_bib55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11154-006-9021-1","article-title":"Noonan syndrome and related disorders: Alterations in growth and puberty","volume":"7","author":"Noonan","year":"2006","journal-title":"Rev Endocr Metabol Disord"},{"key":"10.1016\/j.yapd.2022.03.005_bib56","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00467-003-1158-5","article-title":"Chronic renal insufficiency in children: The 2001 Annual Report of the NAPRTCS","volume":"18","author":"Seikaly","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.yapd.2022.03.005_bib57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/ndt\/gfx190","article-title":"Long-term consequences of renal insufficiency in children: lessons learned from the Dutch LERIC study","volume":"33","author":"Groothoff","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.yapd.2022.03.005_bib58","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1097\/01.ASN.0000089565.04535.4B","article-title":"Hypertension and Progression of Chronic Renal Insufficiency in Children: A Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"14","author":"Mitsnefes","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.yapd.2022.03.005_bib59","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41581-019-0161-4","article-title":"Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease","volume":"15","author":"Drube","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.yapd.2022.03.005_bib60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12882-017-0599-1","article-title":"Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report","volume":"18","author":"Akchurin","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.yapd.2022.03.005_bib61","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ki.1996.108","article-title":"Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone","volume":"49","author":"Fine","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.yapd.2022.03.005_bib62","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s004670000340","article-title":"Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency","volume":"14","author":"Hokken-Koelega","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.yapd.2022.03.005_bib63","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00467-004-1580-3","article-title":"Optimising nutrition in chronic renal insufficiency- growth","volume":"19","author":"Norman","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.yapd.2022.03.005_bib64","article-title":"Committee on Practice and Ambulatory Medicine, Bright Futures Periodicity Schedule Workgroup. 2021 Recommendations for Preventive Pediatric Health Care","volume":"147","year":"2021","journal-title":"Pediatr"},{"key":"10.1016\/j.yapd.2022.03.005_bib65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ghir.2018.12.004","article-title":"Growth hormone therapy in children: research and practice- A review","volume":"44","author":"Collett-Solberg","year":"2019","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.yapd.2022.03.005_bib66","doi-asserted-by":"crossref","first-page":"e205232","DOI":"10.1001\/jamapediatrics.2020.5232","article-title":"Cardiovascular Disease in Former Pediatric Recipients of Growth Hormone: Another Look at Growth Hormone Safety","volume":"175","author":"Grimberg","year":"2021","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.yapd.2022.03.005_bib67","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1590\/S0004-27302011000800009","article-title":"Adverse effects of growth hormone replacement therapy in children","volume":"55","author":"Souza","year":"2011","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.yapd.2022.03.005_bib68","first-page":"1","article-title":"GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults","volume":"174","author":"Allen","year":"2015","journal-title":"Eur Soc Endocrinol"},{"key":"10.1016\/j.yapd.2022.03.005_bib69","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1210\/js.2019-00246","article-title":"US Growth Hormone Use in the Idiopathic Short Stature Era: Trends in Insurer Payments and Patient Financial Burden","volume":"3","author":"Grimberg","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.yapd.2022.03.005_bib70","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MOP.0000000000000505","article-title":"Growth Hormone Treatment for Growth Hormone Deficiency and Idiopathic Short Stature: New Guidelines Shaped by the Presence and Absence of Evidence","volume":"29","author":"Grimberg","year":"2017","journal-title":"Curr Opin Pediatr"}],"container-title":["Advances in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065310122000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065310122000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T20:12:33Z","timestamp":1758744753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065310122000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0065310122000056"],"URL":"https:\/\/doi.org\/10.1016\/j.yapd.2022.03.005","relation":{},"ISSN":["0065-3101"],"issn-type":[{"value":"0065-3101","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Indications for Growth Hormone Therapy","name":"articletitle","label":"Article Title"},{"value":"Advances in Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yapd.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}